THE HEART STUDY

 

The HEART study's enrollment period will be coming to an end soon! So far, this study has enrolled 54 participants and we are extremely appreciative of your contribution to this important research. This study's goal is to enroll 60 individuals so we are working very hard to recruit 6 new participants before enrollment closes. If you are interested, click below to find out more!

A MESSAGE OF APPRECIATION

We are tremendously grateful to our research participants and our community volunteers for making our research a possibility!

RESOURCES OF INTEREST
  • Click here to visit Dr. William Hu's lab page - a neurologist at Emory that we collaborate with

  • Click here to watch past study participants discuss their experience with lumbar punctures

  • Click here to read some Frequently Asked Questions about lumbar punctures

  • Check out some brain-related health stories on "Your Fantastic Mind", a television series created through a partnership between Emory University and Georgia Public Broadcasting.

  • If you are in need of Alzheimer's or dementia related support please take a look at the Alzheimer's Association's Help and Support page

OUR MISSION

The Wharton laboratory is focused on Alzheimer’s prevention and investigates the influence of midlife vascular risk factors on Alzheimer's disease (AD) in mostly cognitively normal populations. We develop observational & clinical trials in hopes of reducing Alzheimer's disease in people most at risk, including individuals with a parental history of AD, African Americans, family caregivers, women and the LGBTQ community.

 

Areas of investigation include:

  • Understanding the contribution of midlife vascular risk factors in AD and developing interventions to target the most relevant AD biomarkers including AD-related brain changes, inflammation, sleep, and heart health, in individuals at high risk for AD.

  • Testing whether certain blood pressure medications penetrate the brain and act on Alzheimer's disease biomarkers, thereby potentially reducing AD risk.

  • Testing potential racial differences in the way that blood pressure medications penetrate the brain and potentially influence AD risk, while at the same time investigating both physiological and sociological factors that may lead to these differences.

  • Understanding how sex hormones in the body and in the brain influence an individual’s risk for AD.

  • Adapting existing AD caregiver interventions to make the information more applicable to African Americans and the LGBTQ community.

WHITNEY WHARTON​

LABORATORY 

 

  • w-facebook
  • Twitter

©Proudly created with Wix.com